MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
26.02
+0.20 (+0.77%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close25.82
Open25.88
Bid26.08 x 800
Ask26.09 x 800
Day's Range25.70 - 26.12
52 Week Range25.47 - 48.77
Volume616,565
Avg. Volume1,205,429
Market Cap2.218B
Beta (3Y Monthly)1.06
PE Ratio (TTM)N/A
EPS (TTM)-0.42
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est34.85
  • Thomson Reuters StreetEvents3 days ago

    Edited Transcript of MD earnings conference call or presentation 2-May-19 2:00pm GMT

    Q1 2019 MEDNAX Inc Earnings Call

  • Markit18 days ago

    See what the IHS Markit Score report has to say about MEDNAX Inc.

    MEDNAX Inc NYSE:MDView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for MD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.28 billion over the last one-month into ETFs that hold MD are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire18 days ago

    MEDNAX to Present at Upcoming Investor Conferences

    MEDNAX, Inc. , today announced that it is scheduled to make presentations at two upcoming investor conferences.

  • Mednax Inc (MD) Q1 2019 Earnings Call Transcript
    Motley Fool22 days ago

    Mednax Inc (MD) Q1 2019 Earnings Call Transcript

    MD earnings call for the period ending March 31, 2019.

  • MEDNAX (MD) Q1 Earnings Miss Estimates, Decline Y/Y
    Zacks22 days ago

    MEDNAX (MD) Q1 Earnings Miss Estimates, Decline Y/Y

    MEDNAX's (MD) first-quarter earnings disappoint with weak revenues and elevated expenses.

  • Business Wire22 days ago

    California Maternal-Fetal Medicine Practice Joins MEDNAX

    MEDNAX, Inc. (MD), today announced its affiliation with Central Coast Perinatal Medical Group, Inc., a private maternal-fetal medicine practice based in Santa Barbara, Calif. Founded in 1993, Central Coast Perinatal is an established group that has provided perinatal services to the Central Coast community for more than 25 years. Comprising three physicians, the practice specializes in care for expectant mothers, including those with high-risk pregnancies.

  • Mednax (MD) Q1 Earnings and Revenues Miss Estimates
    Zacks23 days ago

    Mednax (MD) Q1 Earnings and Revenues Miss Estimates

    Mednax (MD) delivered earnings and revenue surprises of -8.45% and -5.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press23 days ago

    Mednax: 1Q Earnings Snapshot

    The Sunrise, Florida-based company said it had a loss of $2.81 per share. Earnings, adjusted for one-time gains and costs, were 65 cents per share. The results fell short of Wall Street expectations. The ...

  • Business Wire23 days ago

    MEDNAX Reports First Quarter GAAP EPS from Continuing Operations of $0.48; Adjusted EPS from Continuing Operations of $0.65

    Results Reflect Classification of MedData as Discontinued Operations

  • What Should Investors Know About MEDNAX, Inc.'s (NYSE:MD) Future?
    Simply Wall St.24 days ago

    What Should Investors Know About MEDNAX, Inc.'s (NYSE:MD) Future?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! After MEDNAX, Inc.'s (NYSE:MD) recent earnings announcement in December 2018...

  • Is Mednax Inc. (MD) A Good Stock To Buy?
    Insider Monkey29 days ago

    Is Mednax Inc. (MD) A Good Stock To Buy?

    "October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87\. For perspective, there have been only 5 occasions in those 40 years when the S&P 500 declined by greater than 20% from […]

  • Earnings Preview: Mednax (MD) Q1 Earnings Expected to Decline
    Zackslast month

    Earnings Preview: Mednax (MD) Q1 Earnings Expected to Decline

    Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake
    Motley Foollast month

    Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake

    Sometimes, the market gives up on businesses that still have some life left in them.

  • Business Wirelast month

    MEDNAX 2019 First Quarter Conference Call/Webcast Scheduled for Thursday, May 2, 2019

    MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, May 2, 2019 at 10:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2019. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.

  • What Are Analysts Saying About MEDNAX, Inc.'s (NYSE:MD) Earnings Outlook?
    Simply Wall St.2 months ago

    What Are Analysts Saying About MEDNAX, Inc.'s (NYSE:MD) Earnings Outlook?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The latest earnings release MEDNAX, Inc.'s (NYSE:MD) announced in December 2018 showed that the...

  • GuruFocus.com2 months ago

    Stocks That Fell to 3-Year Lows in the Week of April 5

    CVS Health Corp, Walgreens Boots Alliance Inc., Mednax Inc. and Amdocs Ltd. have declined to their respective three-year lows

  • MEDNAX Ties Up With Georgia Neonatology for Better Baby Care
    Zacks2 months ago

    MEDNAX Ties Up With Georgia Neonatology for Better Baby Care

    MEDNAX (MD) forms a partnership with Georgia Neonatology, LLC to improve its pediatric services.

  • Business Wire2 months ago

    Georgia Neonatology Practice Joins MEDNAX

    MEDNAX, Inc. (MD), today announced its affiliation with Georgia Neonatology, LLC, a private neonatology practice based in Athens, Ga. Georgia Neonatology has provided neonatology services to Piedmont Healthcare’s Piedmont Athens Regional Medical Center location since 2013. The practice specializes in neonatal care for pre-term newborns and critically ill babies.

  • Business Wire2 months ago

    MEDNAX Announces Board of Directors Nominees

    MEDNAX, Inc. (MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the nomination of Carlos A. Migoya and Michael A. Rucker to stand for election to the Company’s Board of Directors at its Annual Meeting of Shareholders on May 16, 2019. As previously announced, MEDNAX’s Board and its Nominating and Corporate Governance Committee initiated a process, with the support of the nationally-recognized executive search firm Spencer Stuart, to evaluate the Board’s composition and identify additional director candidates to help drive MEDNAX’s strategy.

  • GuruFocus.com2 months ago

    Stocks That Fell to 3-Year Lows in the Week of March 22

    UBS Group AG (UBS), AutoNation Inc. (AN), Mednax Inc. (MD) and Amdocs Ltd. (DOX) have declined to three-year lows. The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61. UBS is a Swiss investment bank and financial services company.

  • Moody's2 months ago

    MEDNAX, Inc. -- Moody's announces completion of a periodic review of ratings of MEDNAX, Inc.

    Announcement: Moody's announces completion of a periodic review of ratings of MEDNAX, Inc. New York, March 22, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of MEDNAX, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Why Is Mednax (MD) Down 17.6% Since Last Earnings Report?
    Zacks3 months ago

    Why Is Mednax (MD) Down 17.6% Since Last Earnings Report?

    Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Did Changing Sentiment Drive MEDNAX’s Share Price Down By 50%?
    Simply Wall St.3 months ago

    Did Changing Sentiment Drive MEDNAX’s Share Price Down By 50%?

    Many investors define successful investing as beating the market average over the long term. But its virtually certain that sometimes you will buy stocks that fall short of the marketRead More...